Authors:
Schneider, C
Dalakas, MC
Toyka, KV
Said, G
Hartung, HP
Gold, R
Citation: C. Schneider et al., T-cell apoptosis in inflammatory neuromuscular disorders associated with human immunodeficiency virus infection, ARCH NEUROL, 56(1), 1999, pp. 79-83
Citation: K. Murata et Mc. Dalakas, Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies, AM J PATH, 155(2), 1999, pp. 453-460
Citation: Mc. Dalakas, Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases, NEUROLOGY, 51(6), 1998, pp. S2-S8
Citation: Mc. Dalakas, Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis, NEUROLOGY, 51(6), 1998, pp. S37-S45
Authors:
Sambuughin, N
Sivakumar, K
Selenge, B
Lee, HS
Friedlich, D
Baasanjav, D
Dalakas, MC
Goldfarb, LG
Citation: N. Sambuughin et al., Autosomal dominant distal spinal muscular atrophy type V (dSMA-V) and Charcot-Marie-Tooth disease type 2D (CMT2D) segregate within a single large kindred and map to a refined region on chromosome 7p15, J NEUR SCI, 161(1), 1998, pp. 23-28